Literature DB >> 25266072

Vascular-resident CD169-positive monocytes and macrophages control neutrophil accumulation in the kidney with ischemia-reperfusion injury.

Kazunori Karasawa1, Kenichi Asano2, Shigetaka Moriyama3, Mikiko Ushiki3, Misa Monya3, Mayumi Iida3, Erika Kuboki3, Hideo Yagita4, Keiko Uchida5, Kosaku Nitta5, Masato Tanaka6.   

Abstract

Monocytes and kidney-resident macrophages are considered to be involved in the pathogenesis of renal ischemia-reperfusion injury (IRI). Several subsets of monocytes and macrophages are localized in the injured tissue, but the pathologic roles of these cells are not fully understood. Here, we show that CD169(+) monocytes and macrophages have a critical role in preventing excessive inflammation in IRI by downregulating intercellular adhesion molecule-1 (ICAM-1) expression on vascular endothelial cells. Mice depleted of CD169(+) cells showed enhanced endothelial ICAM-1 expression and developed irreversible renal damage associated with infiltration of a large number of neutrophils. The perivascular localization of CD169(+) monocytes and macrophages indicated direct interaction with blood vessels, and coculture experiments showed that the direct interaction of CD169(+) cell-depleted peripheral blood leukocytes augments the expression levels of ICAM-1 on endothelial cells. Notably, the transfer of Ly6C(lo) monocytes into CD169(+) cell-depleted mice rescued the mice from lethal renal injury and normalized renal ICAM-1 expression levels, indicating that the Ly6C(lo) subset of CD169(+) monocytes has a major role in the regulation of inflammation. Our findings highlight the previously unknown role of CD169(+) monocytes and macrophages in the maintenance of vascular homeostasis and provide new approaches to the treatment of renal IRI.
Copyright © 2015 by the American Society of Nephrology.

Entities:  

Keywords:  acute renal failure; immunology and pathology; ischemia-reperfusion; macrophages

Mesh:

Substances:

Year:  2014        PMID: 25266072      PMCID: PMC4378108          DOI: 10.1681/ASN.2014020195

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  46 in total

1.  Chemokine receptor CCR1 regulates inflammatory cell infiltration after renal ischemia-reperfusion injury.

Authors:  Kengo Furuichi; Ji-Liang Gao; Richard Horuk; Takashi Wada; Shuichi Kaneko; Philip M Murphy
Journal:  J Immunol       Date:  2008-12-15       Impact factor: 5.422

2.  Novel subset of CD8{alpha}+ dendritic cells localized in the marginal zone is responsible for tolerance to cell-associated antigens.

Authors:  Chun-Hong Qiu; Yasunobu Miyake; Hitomi Kaise; Hiroshi Kitamura; Osamu Ohara; Masato Tanaka
Journal:  J Immunol       Date:  2009-04-01       Impact factor: 5.422

Review 3.  Pathophysiology of ischaemia-reperfusion injury.

Authors:  D L Carden; D N Granger
Journal:  J Pathol       Date:  2000-02       Impact factor: 7.996

4.  Analysis of fractalkine receptor CX(3)CR1 function by targeted deletion and green fluorescent protein reporter gene insertion.

Authors:  S Jung; J Aliberti; P Graemmel; M J Sunshine; G W Kreutzberg; A Sher; D R Littman
Journal:  Mol Cell Biol       Date:  2000-06       Impact factor: 4.272

5.  Macrophage Wnt7b is critical for kidney repair and regeneration.

Authors:  Shuei-Liong Lin; Bing Li; Sujata Rao; Eun-Jin Yeo; Thomas E Hudson; Brian T Nowlin; Huaying Pei; Lijun Chen; Jie J Zheng; Thomas J Carroll; Jeffrey W Pollard; Andrew P McMahon; Richard A Lang; Jeremy S Duffield
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-16       Impact factor: 11.205

Review 6.  Macrophage diversity in renal injury and repair.

Authors:  Sharon D Ricardo; Harry van Goor; Allison A Eddy
Journal:  J Clin Invest       Date:  2008-11       Impact factor: 14.808

7.  Langerhans cell (LC) proliferation mediates neonatal development, homeostasis, and inflammation-associated expansion of the epidermal LC network.

Authors:  Laurent Chorro; Aurélien Sarde; Mei Li; Kevin J Woollard; Pierre Chambon; Bernard Malissen; Adrien Kissenpfennig; Jean-Baptiste Barbaroux; Richard Groves; Frédéric Geissmann
Journal:  J Exp Med       Date:  2009-12-07       Impact factor: 14.307

8.  Fractalkine receptor (CX3CR1) inhibition is protective against ischemic acute renal failure in mice.

Authors:  Dong-Jin Oh; Belda Dursun; Zhibin He; Lawrence Lu; Thomas S Hoke; Danica Ljubanovic; Sarah Faubel; Charles L Edelstein
Journal:  Am J Physiol Renal Physiol       Date:  2007-11-14

9.  Monocyte chemoattractant protein-1 contributes to gut homeostasis and intestinal inflammation by composition of IL-10-producing regulatory macrophage subset.

Authors:  Yasuhiro Takada; Tadakazu Hisamatsu; Nobuhiko Kamada; Mina T Kitazume; Haruki Honda; Yosuke Oshima; Riko Saito; Tetsuro Takayama; Taku Kobayashi; Hiroshi Chinen; Yohei Mikami; Takanori Kanai; Susumu Okamoto; Toshifumi Hibi
Journal:  J Immunol       Date:  2010-01-27       Impact factor: 5.422

10.  Hematopoiesis: an evolving paradigm for stem cell biology.

Authors:  Stuart H Orkin; Leonard I Zon
Journal:  Cell       Date:  2008-02-22       Impact factor: 41.582

View more
  33 in total

1.  Dependence of Glomerulonephritis Induction on Novel Intraglomerular Alternatively Activated Bone Marrow-Derived Macrophages and Mac-1 and PD-L1 in Lupus-Prone NZM2328 Mice.

Authors:  Sun-Sang J Sung; Yan Ge; Chao Dai; Hongyang Wang; Shu Man Fu; Rahul Sharma; Young S Hahn; Jing Yu; Thu H Le; Mark D Okusa; Warren K Bolton; Jessica R Lawler
Journal:  J Immunol       Date:  2017-02-20       Impact factor: 5.422

2.  Maea expressed by macrophages, but not erythroblasts, maintains postnatal murine bone marrow erythroblastic islands.

Authors:  Qiaozhi Wei; Philip E Boulais; Dachuan Zhang; Sandra Pinho; Masato Tanaka; Paul S Frenette
Journal:  Blood       Date:  2019-01-23       Impact factor: 22.113

Review 3.  Macrophages under pressure: the role of macrophage polarization in hypertension.

Authors:  Sailesh C Harwani
Journal:  Transl Res       Date:  2017-11-08       Impact factor: 7.012

Review 4.  The role of tissue resident cells in neutrophil recruitment.

Authors:  Nancy D Kim; Andrew D Luster
Journal:  Trends Immunol       Date:  2015-08-18       Impact factor: 16.687

5.  CD169+ macrophages: regulators of neutrophil trafficking to injured kidneys.

Authors:  Hee-Seong Jang; Hamid Rabb; Babu J Padanilam
Journal:  J Am Soc Nephrol       Date:  2014-09-29       Impact factor: 10.121

Review 6.  The contribution of tumor-associated macrophages in glioma neo-angiogenesis and implications for anti-angiogenic strategies.

Authors:  Changbin Zhu; Johan M Kros; Caroline Cheng; Dana Mustafa
Journal:  Neuro Oncol       Date:  2017-10-19       Impact factor: 12.300

Review 7.  The Role of Myeloid Cells in Acute Kidney Injury and Kidney Repair.

Authors:  Leyuan Xu
Journal:  Kidney360       Date:  2021-09-22

8.  Sphingosine 1-Phosphate Receptor 3-Deficient Dendritic Cells Modulate Splenic Responses to Ischemia-Reperfusion Injury.

Authors:  Amandeep Bajwa; Liping Huang; Elvira Kurmaeva; Joseph C Gigliotti; Hong Ye; Jacqueline Miller; Diane L Rosin; Peter I Lobo; Mark D Okusa
Journal:  J Am Soc Nephrol       Date:  2015-08-18       Impact factor: 10.121

9.  Fibrotic liver has prompt recovery after ischemia-reperfusion injury.

Authors:  Takanori Konishi; Rebecca M Schuster; Holly S Goetzman; Charles C Caldwell; Alex B Lentsch
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2020-01-21       Impact factor: 4.052

10.  Tissue-resident macrophages provide a pro-tumorigenic niche to early NSCLC cells.

Authors:  Erica Dalla; Andrew M Leader; Jessica LeBerichel; María Casanova-Acebes; Jovan Nikolic; Blanca M Morales; Markus Brown; Christie Chang; Leanna Troncoso; Steven T Chen; Ana Sastre-Perona; Matthew D Park; Alexandra Tabachnikova; Maxime Dhainaut; Pauline Hamon; Barbara Maier; Catherine M Sawai; Esperanza Agulló-Pascual; Markus Schober; Brian D Brown; Boris Reizis; Thomas Marron; Ephraim Kenigsberg; Christine Moussion; Philippe Benaroch; Julio A Aguirre-Ghiso; Miriam Merad
Journal:  Nature       Date:  2021-06-16       Impact factor: 69.504

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.